Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genetic Ablation of Sarm1 Mitigates Disease Acceleration after Traumatic Brain Injury in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Annals of Neurology(2025)10.1002/ana.27174Source: DataRank Database

Genetic Ablation of Sarm1 Mitigates Disease Acceleration after Traumatic Brain Injury in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis is a research paper published in Annals of Neurology (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.98)OA: bronzeTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Sean R. Simonini,James Bouley,Alexandra Weiss ORCID,Robert H. Brown ORCID,Nils Henninger ORCID

Live enrichment

PubMed:39791335 PMC:PMC12011539 OpenAlex:https://openalex.org/W4406246270

National Institute of Neurological Disorders and Stroke

Grant: NS131756

NINDS NIH HHS

Grant: R21 NS131756

Moloney Fellowship

Angel Fund for ALS Research

Moloney Fellowship

Angel Fund for ALS Research

FWCI

2.98

Citation Percentile

0.9%

Citation Trend

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.27174

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.27174

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.27174

journalhttps://doi.org/10.1002/ana.27174

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39791335

Fields of Study

Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesNeurogenetic and Muscular Disorders ResearchAnimalsAmyotrophic Lateral SclerosisMiceMice, TransgenicArmadillo Domain ProteinsDisease Models, AnimalCytoskeletal ProteinsSuperoxide Dismutase-1MaleBrain Injuries, TraumaticFemaleMice, KnockoutDisease Progression

MeSH Terms

Brain Injuries, TraumaticSuperoxide Dismutase-1Amyotrophic Lateral SclerosisAnimalsCytoskeletal ProteinsDisease Models, AnimalFemaleMaleMice, TransgenicMice, KnockoutDisease ProgressionArmadillo Domain ProteinsMice

Keywords

SOD1Amyotrophic lateral sclerosisNeuropathologyMedicineTraumatic brain injuryGenetically modified mousePathologyPathogenesisInternal medicineNeuroscienceEndocrinologyTransgeneBiologyDiseaseGeneticsPsychiatry

Sustainable Development Goals

SDG 0: Good health and well-being